Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain

L. Padua, C. Briani, A. Truini, I. Aprile, D. Bouhassirà, G. Cruccu, S. Jann, E. Nobile-Orazio, C. Pazzaglia, A. Morini, M. Mondelli, P. Ciaramitaro, G. Cavaletti, D. Cocito, R. Fazio, L. Santoro, F. Galeotti, M. Carpo, R. Plasmati, L. BenedettiA. Schenone

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Pain is a subjective condition that cannot be objectively measured; for this reason, self patient-perspective is crucial. Recently, several screening tools to discriminate between nociceptive and neuropathic pain have been developed. We aimed at assessing the consistence and discrepancy of two widely used screening tools, The Douleur Neuropathique 4 (DN4) and the 6-item questionnaire (ID-Pain), by comparing their ability in discriminating neuropathic from nociceptive pain. DN4 and ID-Pain were administered to 392 Italian patients attending 16 outpatient services for peripheral nerve diseases. Based on medical history, clinical findings and diagnostic tools, patients were divided into two groups (neuropathic and nociceptive). Globally, ID-Pain identified neuropathic pain in 60 % of patients (38 % probable, 22 % likely). Interestingly also DN4 diagnosed neuropathic pain in 60 % of cases. A discrepancy was observed in 16 % of cases. DN4 and ID-Pain resulted to be highly interrelated in the identification of neuropathic pain. Sensitivity of DN4 was 82 % and specificity was 81 %, while ID-Pain (considering both probable and likely groups) showed sensitivity 78 % and specificity 74 %. Reliable screening tools for neuropathic pain are well related between them; hence, they are available for researchers and clinicians who may choose the most appropriate for their activity. Since the gold standard for the diagnosis and treatment of neuropathic pain cannot do without a neurological evaluation, perhaps DN4, that includes physician objective measures, may help reducing the percentage of dubious cases. Conversely, when needing a more agile tool (not needing a physician) ID-Pain may be adopted.

Original languageEnglish
Pages (from-to)373-377
Number of pages5
JournalNeurological Sciences
Volume34
Issue number3
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Neuralgia
Pain
Nociceptive Pain
Physicians
Aptitude
Peripheral Nervous System Diseases
Ambulatory Care
Research Personnel
Sensitivity and Specificity

Keywords

  • Neuropathic pain
  • Pain
  • Patient-oriented
  • Peripheral nervous system
  • Questionnaire

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology

Cite this

Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain. / Padua, L.; Briani, C.; Truini, A.; Aprile, I.; Bouhassirà, D.; Cruccu, G.; Jann, S.; Nobile-Orazio, E.; Pazzaglia, C.; Morini, A.; Mondelli, M.; Ciaramitaro, P.; Cavaletti, G.; Cocito, D.; Fazio, R.; Santoro, L.; Galeotti, F.; Carpo, M.; Plasmati, R.; Benedetti, L.; Schenone, A.

In: Neurological Sciences, Vol. 34, No. 3, 03.2013, p. 373-377.

Research output: Contribution to journalArticle

Padua, L, Briani, C, Truini, A, Aprile, I, Bouhassirà, D, Cruccu, G, Jann, S, Nobile-Orazio, E, Pazzaglia, C, Morini, A, Mondelli, M, Ciaramitaro, P, Cavaletti, G, Cocito, D, Fazio, R, Santoro, L, Galeotti, F, Carpo, M, Plasmati, R, Benedetti, L & Schenone, A 2013, 'Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain', Neurological Sciences, vol. 34, no. 3, pp. 373-377. https://doi.org/10.1007/s10072-012-1011-3
Padua, L. ; Briani, C. ; Truini, A. ; Aprile, I. ; Bouhassirà, D. ; Cruccu, G. ; Jann, S. ; Nobile-Orazio, E. ; Pazzaglia, C. ; Morini, A. ; Mondelli, M. ; Ciaramitaro, P. ; Cavaletti, G. ; Cocito, D. ; Fazio, R. ; Santoro, L. ; Galeotti, F. ; Carpo, M. ; Plasmati, R. ; Benedetti, L. ; Schenone, A. / Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain. In: Neurological Sciences. 2013 ; Vol. 34, No. 3. pp. 373-377.
@article{585acb79e72e4815ad2a96a295b5afda,
title = "Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain",
abstract = "Pain is a subjective condition that cannot be objectively measured; for this reason, self patient-perspective is crucial. Recently, several screening tools to discriminate between nociceptive and neuropathic pain have been developed. We aimed at assessing the consistence and discrepancy of two widely used screening tools, The Douleur Neuropathique 4 (DN4) and the 6-item questionnaire (ID-Pain), by comparing their ability in discriminating neuropathic from nociceptive pain. DN4 and ID-Pain were administered to 392 Italian patients attending 16 outpatient services for peripheral nerve diseases. Based on medical history, clinical findings and diagnostic tools, patients were divided into two groups (neuropathic and nociceptive). Globally, ID-Pain identified neuropathic pain in 60 {\%} of patients (38 {\%} probable, 22 {\%} likely). Interestingly also DN4 diagnosed neuropathic pain in 60 {\%} of cases. A discrepancy was observed in 16 {\%} of cases. DN4 and ID-Pain resulted to be highly interrelated in the identification of neuropathic pain. Sensitivity of DN4 was 82 {\%} and specificity was 81 {\%}, while ID-Pain (considering both probable and likely groups) showed sensitivity 78 {\%} and specificity 74 {\%}. Reliable screening tools for neuropathic pain are well related between them; hence, they are available for researchers and clinicians who may choose the most appropriate for their activity. Since the gold standard for the diagnosis and treatment of neuropathic pain cannot do without a neurological evaluation, perhaps DN4, that includes physician objective measures, may help reducing the percentage of dubious cases. Conversely, when needing a more agile tool (not needing a physician) ID-Pain may be adopted.",
keywords = "Neuropathic pain, Pain, Patient-oriented, Peripheral nervous system, Questionnaire",
author = "L. Padua and C. Briani and A. Truini and I. Aprile and D. Bouhassir{\`a} and G. Cruccu and S. Jann and E. Nobile-Orazio and C. Pazzaglia and A. Morini and M. Mondelli and P. Ciaramitaro and G. Cavaletti and D. Cocito and R. Fazio and L. Santoro and F. Galeotti and M. Carpo and R. Plasmati and L. Benedetti and A. Schenone",
year = "2013",
month = "3",
doi = "10.1007/s10072-012-1011-3",
language = "English",
volume = "34",
pages = "373--377",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "3",

}

TY - JOUR

T1 - Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain

AU - Padua, L.

AU - Briani, C.

AU - Truini, A.

AU - Aprile, I.

AU - Bouhassirà, D.

AU - Cruccu, G.

AU - Jann, S.

AU - Nobile-Orazio, E.

AU - Pazzaglia, C.

AU - Morini, A.

AU - Mondelli, M.

AU - Ciaramitaro, P.

AU - Cavaletti, G.

AU - Cocito, D.

AU - Fazio, R.

AU - Santoro, L.

AU - Galeotti, F.

AU - Carpo, M.

AU - Plasmati, R.

AU - Benedetti, L.

AU - Schenone, A.

PY - 2013/3

Y1 - 2013/3

N2 - Pain is a subjective condition that cannot be objectively measured; for this reason, self patient-perspective is crucial. Recently, several screening tools to discriminate between nociceptive and neuropathic pain have been developed. We aimed at assessing the consistence and discrepancy of two widely used screening tools, The Douleur Neuropathique 4 (DN4) and the 6-item questionnaire (ID-Pain), by comparing their ability in discriminating neuropathic from nociceptive pain. DN4 and ID-Pain were administered to 392 Italian patients attending 16 outpatient services for peripheral nerve diseases. Based on medical history, clinical findings and diagnostic tools, patients were divided into two groups (neuropathic and nociceptive). Globally, ID-Pain identified neuropathic pain in 60 % of patients (38 % probable, 22 % likely). Interestingly also DN4 diagnosed neuropathic pain in 60 % of cases. A discrepancy was observed in 16 % of cases. DN4 and ID-Pain resulted to be highly interrelated in the identification of neuropathic pain. Sensitivity of DN4 was 82 % and specificity was 81 %, while ID-Pain (considering both probable and likely groups) showed sensitivity 78 % and specificity 74 %. Reliable screening tools for neuropathic pain are well related between them; hence, they are available for researchers and clinicians who may choose the most appropriate for their activity. Since the gold standard for the diagnosis and treatment of neuropathic pain cannot do without a neurological evaluation, perhaps DN4, that includes physician objective measures, may help reducing the percentage of dubious cases. Conversely, when needing a more agile tool (not needing a physician) ID-Pain may be adopted.

AB - Pain is a subjective condition that cannot be objectively measured; for this reason, self patient-perspective is crucial. Recently, several screening tools to discriminate between nociceptive and neuropathic pain have been developed. We aimed at assessing the consistence and discrepancy of two widely used screening tools, The Douleur Neuropathique 4 (DN4) and the 6-item questionnaire (ID-Pain), by comparing their ability in discriminating neuropathic from nociceptive pain. DN4 and ID-Pain were administered to 392 Italian patients attending 16 outpatient services for peripheral nerve diseases. Based on medical history, clinical findings and diagnostic tools, patients were divided into two groups (neuropathic and nociceptive). Globally, ID-Pain identified neuropathic pain in 60 % of patients (38 % probable, 22 % likely). Interestingly also DN4 diagnosed neuropathic pain in 60 % of cases. A discrepancy was observed in 16 % of cases. DN4 and ID-Pain resulted to be highly interrelated in the identification of neuropathic pain. Sensitivity of DN4 was 82 % and specificity was 81 %, while ID-Pain (considering both probable and likely groups) showed sensitivity 78 % and specificity 74 %. Reliable screening tools for neuropathic pain are well related between them; hence, they are available for researchers and clinicians who may choose the most appropriate for their activity. Since the gold standard for the diagnosis and treatment of neuropathic pain cannot do without a neurological evaluation, perhaps DN4, that includes physician objective measures, may help reducing the percentage of dubious cases. Conversely, when needing a more agile tool (not needing a physician) ID-Pain may be adopted.

KW - Neuropathic pain

KW - Pain

KW - Patient-oriented

KW - Peripheral nervous system

KW - Questionnaire

UR - http://www.scopus.com/inward/record.url?scp=84879694810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879694810&partnerID=8YFLogxK

U2 - 10.1007/s10072-012-1011-3

DO - 10.1007/s10072-012-1011-3

M3 - Article

C2 - 22434411

AN - SCOPUS:84879694810

VL - 34

SP - 373

EP - 377

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 3

ER -